Aurora Cannabis Inc.

ACB

$4.10

Name : Aurora Cannabis Inc.

Sector : Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Mark. Cap: $259,571,232.00

EPSttm : -0.65

Aurora Cannabis Inc.

$4.10

1.44%

$0.06

ACB — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

11.55

Margin Of Safety %

Put/Call OI Ratio

0.4

EPS Next Q Diff

-0.07

EPS Last/This Y

EPS This/Next Y

0.28

Price

4.1

Target Price

3.85

Analyst Recom

2.43

Performance Q

44.88

Upside

-1,303.7%

Beta

0.64

Ticker: ACB

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-08-28	ACB	4	0.41	0.62	37328
2026-08-31	ACB	4.05	0.41	0.38	37390
2026-09-01	ACB	4.05	0.41	0.14	37465
2026-09-02	ACB	4.03	0.41	0.04	37404
2026-09-03	ACB	3.9	0.41	0.83	37474
2026-09-04	ACB	3.95	0.42	5.06	37702
2026-09-08	ACB	3.87	0.43	9.48	38211
2026-09-09	ACB	3.88	0.45	0.29	38635
2026-09-10	ACB	3.72	0.45	2.25	38778
2026-09-11	ACB	3.74	0.45	3.79	38750
2026-09-14	ACB	3.82	0.47	0.26	39183
2026-09-15	ACB	3.84	0.47	2.29	39258
2026-09-16	ACB	3.83	0.47	1.69	39342
2026-09-17	ACB	3.86	0.47	0.28	39437
2026-09-18	ACB	3.87	0.47	0.12	39479
2026-09-21	ACB	4.03	0.46	0.01	27240
2026-09-22	ACB	4.26	0.43	0.02	28501
2026-09-23	ACB	4.23	0.40	0.01	29546
2026-09-24	ACB	4.17	0.40	0.05	29825
2026-09-25	ACB	4.11	0.40	2.92	29897
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-08-28	ACB	4.00	-	-	-0.17
2026-08-31	ACB	4.05	-	-	-0.17
2026-09-01	ACB	4.05	-	-	-0.17
2026-09-02	ACB	4.03	-	-	-0.17
2026-09-03	ACB	3.89	-	-	-0.17
2026-09-04	ACB	3.95	-	-	-0.17
2026-09-08	ACB	3.87	-	-	-0.17
2026-09-09	ACB	3.88	-	-	-0.17
2026-09-10	ACB	3.72	-	-	-0.17
2026-09-11	ACB	3.74	-	-	-0.17
2026-09-14	ACB	3.82	-	-	-0.17
2026-09-15	ACB	3.84	-	-	-0.17
2026-09-16	ACB	3.84	-	-	-0.17
2026-09-17	ACB	3.86	-	-	-0.17
2026-09-18	ACB	3.86	-	-	-0.17
2026-09-21	ACB	4.03	-	-	-0.17
2026-09-22	ACB	4.27	-	-	-0.17
2026-09-23	ACB	4.23	-	-	-0.17
2026-09-24	ACB	4.16	-	-	-0.17
2026-09-25	ACB	4.10	-	-	-0.17
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-08-28	ACB	0.00	-0.06	11.30
2026-08-31	ACB	0.00	-0.06	11.30
2026-09-01	ACB	0.00	-0.06	11.30
2026-09-02	ACB	0.00	-0.06	11.30
2026-09-03	ACB	0.00	-0.06	11.30
2026-09-04	ACB	0.00	-0.06	11.30
2026-09-08	ACB	0.00	-0.06	11.30
2026-09-09	ACB	0.00	-0.06	11.30
2026-09-10	ACB	0.00	-0.06	11.30
2026-09-11	ACB	0.00	-0.06	11.35
2026-09-14	ACB	0.00	-0.02	11.35
2026-09-15	ACB	0.00	-0.02	11.35
2026-09-16	ACB	0.00	-0.02	11.35
2026-09-17	ACB	0.00	-0.02	11.35
2026-09-18	ACB	0.00	-0.02	11.35
2026-09-21	ACB	0.00	-0.02	11.35
2026-09-23	ACB	0.00	-0.02	11.35
2026-09-24	ACB	0.00	-0.02	11.35
2026-09-25	ACB	0.00	-0.02	11.55
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

0.04

Avg. EPS Est. Current Quarter

-0.09

Avg. EPS Est. Next Quarter

-0.03

Insider Transactions

Institutional Transactions

-0.02

Beta

0.64

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

95.3

Max Drawdown 5-Year %

-97

Target Price

3.85

P/E

Forward P/E

54.14

PEG

P/S

1.27

P/B

0.7

P/Free Cash Flow

EPS

-1.41

Average EPS Est. Cur. Y

-0.17

EPS Next Y. (Est.)

0.11

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-38.37

Relative Volume

0.51

Return on Equity vs Sector %

-49.1

Return on Equity vs Industry %

-28.9

EPS 1 7Days Diff

EPS 1 30Days Diff

0.15

EBIT Estimation

◆ ACB Healthcare

$4.10

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

0/20

Pullback

10/25

Volume

11/15

Valuation

9/20

TP/AR

1/10

Options

6/10

RSI

62.4

Range 1M

66.9%

Sup Dist

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

3/25

Growth

23/30

Estimates

1/20

Inst/Vol

3/15

Options

6/10

EPS Yr

86.3%

EPS NY

161.8%

52W%

37.4%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🔴 SELL -6.1% upside

Quality

2/30

Valuation

2/30

Growth

18/25

Stability

6/10

LT Trend

1/5

Upside

-6.1%

Quality

ACB — P/E HistoricalDrug Manufacturers - Specialty & Generic

Aurora Cannabis Inc.

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Employees: 1028

Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis products in Canada and internationally. The company offers pharmaceutical-grade cannabis products; and medical and consumer cannabis products. It also provides harvested cannabis, trim, cannabis oils, capsules, edibles, vaporizers, dried and fresh cannabis, cannabis plants, cannabis seeds, edible cannabis, cannabis extracts, flowers, vapes / inhalable extracts, edibles / pastilles, concentrates, and cannabis topicals; and patient counseling and outreach services. Its brand portfolio includes Aurora, Being, CanniMed, CraftPlant, Daily Special, Drift, Greybeard, IndiMed, MedReleaf, Pedanios, San Raf, Tasty's, Whistler, and WMMC. The company also engages in pharmacy activities. Aurora Cannabis Inc. was founded in 2013 and is headquartered in Edmonton, Canada.

ACB

Latest News

—

Caricamento notizie per ACB…

stock quote shares ACB – Aurora Cannabis Inc. Stock Price stock today

news today ACB – Aurora Cannabis Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch ACB – Aurora Cannabis Inc. yahoo finance google finance

stock history ACB – Aurora Cannabis Inc. invest stock market

stock prices ACB premarket after hours

ticker ACB fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: ACB

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y